The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Fateeva V.V.

Sechenov First Мoscow State Medical University, Moscow, Russia

Pathogenesis of endothelial dysfunction in cerebral atherosclerosis and their correction

Authors:

Fateeva V.V.

More about the authors

Read: 1166 times


To cite this article:

Fateeva VV. Pathogenesis of endothelial dysfunction in cerebral atherosclerosis and their correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(12):67‑70. (In Russ.)
https://doi.org/10.17116/jnevro201711712167-70

References:

  1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, Dermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Roger VL, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121:46-215. https://doi.org/10.1161/CIRCULATIONAHA.109.192666
  2. Butt HZ, Atturu G, London NJ, Sayers RD, Bown MJ. Telomere length dynamics in vascular disease: a review. Eur J Vasc Endovasc Surg. 2010;40:17-26. https://doi.org/10.1016/j.ejvs.2010.04.012
  3. Kimura Y, Matsumoto M, Den YB, Iwai K, Munehira J, Hattori H, Hoshino T, Yamada K, Kawanishi K, Tsuchiya H. Impaired endothelial function in hypertensive elderly patients evaluated by high resolution ultrasonography. Can J Cardiol. 1999;15:563-568. PMID: 10350666.
  4. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002;346:1954-1962. https://doi.org/10.1056/NEJMoa013591
  5. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension. 2004;44:248-252. https://doi.org/10.1161/01.HYP.0000138070.47616.9d
  6. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res. 2000;86:85-90. https://doi.org/10.1161/01.RES.86.9.e85
  7. Sowers JR. Hypertension, angiotensin II, and oxidative stress. N Engl J Med. 2002;346(25):1999-2001. https://doi.org/10.1056/NEJMe020054
  8. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Oxidative stress and endothelial function in cardiovascular diseases. Circ J. 2009;73:411-418. https://doi.org/10.1253/circj.CJ-08-1102
  9. Higashi Y, Nakagawa K, Kimura M, Noma K, Sasaki S, Hara K, Goto C, Oshima T, Chayama K, Yoshizumi M. Low body mass index is a risk factor for impaired endothelium-dependent vasodilation in humans: role of nitric oxide and oxidative stress. J Am Coll Cardiol. 2003;42:256-263. https://doi.org/10.1016/S0735-1097(00)01177-3
  10. Higashi Y, Sasaki S, Nakagawa K, Kurisu S, Yoshimizu A, Matsuura H, Kajiyama G, Oshima T. A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers, diuretics on reactive hyperemia in patients with essential hypertension: a multicenter study. J Am Coll Cardiol. 2000;35:284-291. https://doi.org/10.1016/S0735-1097(99)00561-6
  11. Tsutsui M, Shimokawa H, Otsuji Y. Yanagihara N. Pathophysiological relevance of NO signaling in the cardiovascular system: novel insight from mice lacking all NO synthases. Pharmacol Ther. 2010;128:499-508. https://doi.org/10.1016/j.pharmthera.2010.08.010
  12. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002;346:1954-1962.
  13. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104:191-196. https://doi.org/10.1161/01.CIR.104.2.191
  14. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593-600. https://doi.org/10.1056/NEJMoa022287
  15. Umemura T, Soga J, Hidaka T, Takemoto H, Nakamura S, Jitsuiki D, Nishioka K, Goto C, Teragawa H, Yoshizumi M, Chayama K, Higashi Y. Aging and hypertension are independent risk factors for reduced number of circulating endothelial progenitor cells. Am J Hypertens. 2008;21:1203-1209. https://doi.org/10.1038/ajh.2008.278
  16. Heiss C, Amabile N, Lee AC, Real WM, Schick SF, Lao D, Wong ML, Jahn S, Angeli FS, Minasi P, Springer ML, Hammond SK, Glantz SA, Grossman W, Balmes JR., Yeghiazarians Y. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J Am Coll Cardiol. 2008;51:1760-1771. https://doi.org/10.1016/j.jacc.2008.01.040
  17. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840-844. https://doi.org/10.1161/01.RES.87.10.840
  18. Irani K. Oxidant signaling in vascular cell growth, death and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelail cell mitogenic and apoptotic signaling. Circ Res. 2000;87:179-183. https://doi.org/10.1161/01.RES.87.3.179
  19. Dzau VJ. Theodore Cooper Lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension. 2001;37:1047-1052. https://doi.org/10.1161/01.HYP.37.4.1047
  20. Zalba G, Beaumont FJ, San Jose G, Fortuno A, Fortuno MA, Etayo JC, Diez J. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension. 2000;35: 1055-1061.
  21. Liu H, Yang Y, Huang G, Tan S, Liu Y. Positive association of pro-inflammatory biomarkers and increased oxidative stress in the healthy elderly. Arch Gerontol Geriatr. 2012;54:8-12. https://doi.org/10.1016/j.archger.2011.05.016
  22. Yamashita N, Hoshida S, Otsu K, Asahi M, Kuzuya T, Hori M. Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation. J Exp Med. 1999;189:1699-1706.
  23. Epstein OI. Release-activity (a modern view of homeopathy and non-homoeopathy). M.: Publishing house RAMS; 2017. (In Russ.)
  24. Pokrovsky MV, Kochkarov VI, Pokrovskaya TG, Artyushkova EB, Pashin EN, Danilenko LM, Korokin MV, Belous AS, Korokina LV, Malykhin VA, Zaloznykh YI, Brusnik MS, Zhavbert ES. A comparative study of potential endothelial protectors and the preparation of impaza in modeling the deficiency of nitric oxide. Bul expert Biol and honey. 2009;148(8):154-157. (In Russ.)
  25. Belous AS, Arustamova AA, Pokrovsky MV, Korokin MV, Gudyrev OS, Belous VS. Evaluation of the correction of L-Name and hypoestrogen-induced endothelial dysfunction with the preparation of impaza. Scientific bulletins of the Belgorod State University. Series: Medicine. Pharmacy. 2011;4(13):116-120. (In Russ.)
  26. Хакимова Г.Р., Воронина Т.А., Дугина Ю.Л., Эртузун И.А., Эпштейн О.И. Спектр фармакологических эффектов антител к белку S-100 в релиз-активной форме и механизмы их реализации. Журнал неврологии и психиатрии им. С.С. Корсакова. 2016;116(4):100-113. Khakimova GR, Voronina TA, Dugina YL, Ertuzun IA, Epstein OI. Spectrum of pharmacological effects of antibodies to protein S-100 in release-active form and mechanisms of their realization. Journal of Neurology and Psychiatry im. S.S. Korsakov. 2016;116(4):100-113. (In Russ.)]. https://doi.org/10.17116/jnevro201611641100-113
  27. Ganina KK, Dugina YUL, Zhavbert YeS, Ertuzun IA, Epshteyn OI, Mukhin VN, Abdurasulova IN. Antiamnesticheskoye deystviye Divazy i yeye komponentov na modeli b-amiloidnoy amnezii u krys. Journal of Neurology and Psychiatry im. S.S. Korsakov. 2016;116(9):69-74. (In Russ.) https://doi.org/10.17116/jnevro20161169169-74
  28. Zhavbert ES, Guryanova NN, Surkova EI, Dugina YL, Kachaeva EV, Epshtein OI. Investigation of the influence of Divazy on the processes of lipid peroxidation. XXI Russian National Congress «Man and medicine»; 2014. (In Russ.)
  29. Fateeva VV, Kolokolov OV, Zakharova NB, Maleina AYu, Abramova TP, Fisun AV, Kolokolova AM, Makarov NS. Narusheniye sna i kognitivnykh funktsiy kak proyavleniye khronicheskoy ishemii golovnogo mozga i patogeneticheskiye osnovy ikh korrektsii. Lechashchiy vrach. 2016;5:1-6. (In Russ.)
  30. Fateeva VV, Shumakher GI, Vorob’yeva YeN, Khoreva MA, Voskanyan LR. Effektivnost’ i bezopasnost’ primeneniya preparata divaza v terapii patsiyentov s khronicheskoy ishemiyey golovnogo mozga. Journal of Neurology and Psychiatry im. S.S. Korsakov. 2017;117(2):32-37. (In Russ.) https://doi.org/10.17116/jnevro20171172132-37
  31. Chukanova EI, Bogolepova AN, Chukanova AS. Experience of the use of the drug divaz in the therapy of cerebrovascular insufficiency. Journal of Neurology and Psychiatry im. S.S. Korsakov. 2015;115(6):110-114. (In Russ.)
  32. Fateeva V.V., Vorobyova O.V. Markers of endothelial dysfunction in chronic cerebral ischemia. Journal of Neurology and Psychiatry im. S.S. Korsakov. 2017;117(4):106-110. (In Russ.) https://doi.org/10.17116/jnevro201711741107-111
  33. Dadasheva M.N., Taranenko N.YU., Agafonov B.V. Innovatsionnaya terapiya tserebrovaskulyarnykh zabolevaniy u bol’nykh s variabel’noy arterial’noy gipertenziyey. Prakticheskaya meditsina. 2015;5(90):221-224. (In Russ.)
  34. Parfenov VA, Kamchatnov PR, Vorobyova OV, Gustov AV, Glushkov KS, Doronina OB. Results of a multicenter study of the efficacy and safety of the use of the divaz preparation for asthenic and mild or moderate cognitive disorders in the elderly and senile age. Journal of Neurology and Psychiatry im. S.S. Korsakov. 2017;117(9):43-50. (In Russ.) https://doi.org/10.17116/jnevro20171179143-50
  35. Mudrova O.A., Shchekolova N.B., Borikov F.A. Effektivnost’ preparata divaza v rannem vosstanovitel’nom periode ishemicheskogo insul’ta. Journal of Neurology and Psychiatry im. S.S. Korsakov. 2016;116(3):48-53. (In Russ.) https://doi.org/10.17116/jnevro20161163248-53

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.